1434 GMT - Philips's sales drop in China overshadows its return to a positive order intake in the fourth quarter, Jefferies analysts Julien Dormois and Martinien Rula say in a note. The Dutch medical devices company posted a double-digit decline in China sales in 4Q but grew its order intake on positive U.S. momentum, Jefferies says. "Overall, we remain concerned that recent order trends will put pressure on sales growth well into 2025," they say. Market conditions in China are expected to remain uncertain in 2025 as macroeconomic challenges persist, the analysts say. Shares are down 12% at 23.81 euros.(helena.smolak@wsj.com)
(END) Dow Jones Newswires
February 19, 2025 09:34 ET (14:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。